SCHEMBL217913

SCHEMBL217913

OC[C]1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL372657 0.96
SCHEMBL1942581 0.96
SCHEMBL662260 0.92
SCHEMBL1515186 0.84
SCHEMBL9647392 0.79
SCHEMBL6607326 0.76 CA2 (0.32)
SCHEMBL4598920 0.76
SCHEMBL6055461 0.74 CA2 (0.31)
SCHEMBL6588360 0.69
SCHEMBL19459252 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 403 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024003259-A1 TEAD INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2024-01-04 WO claimed
CN-112479884-B Polymerizable compound and application thereof 晶美晟光电材料(南京)有限公司 2023-11-24 CN claimed
WO-2020248299-A1 LIQUID CRYSTAL COMPOSITION HAVING NEGATIVE DIELECTRIC CONSTANT, AND APPLICATION THEREOF 晶美晟光电材料(南京)有限公司 2020-12-17 WO claimed
WO-2020034759-A1 LIQUID CRYSTAL COMPOSITION HAVING HIGH DIELECTRIC CONSTANT AND APPLICATION THEREOF 晶美晟光电材料(南京)有限公司 2020-02-20 WO claimed
EP-3363788-A1 CANNABINOID RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2018-08-22 EP claimed
EP-2958928-B1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3) Bayer Pharma AG (DE) 2018-03-28 EP claimed
US-9714266-B2 Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3) BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-07-25 US claimed
US-20160024142-A1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3) BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-01-28 US claimed
EP-2958928-A1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3) Bayer Pharma Aktiengesellschaft (DE) 2015-12-30 EP claimed
CN-105008382-A Estra-1, 3,5(10), 16-tetraene-3-carboxamides for the inhibition of 17 beta-hydroxysteroid dehydrogenase (AKR 1C 3) Bayer Pharma AG 2015-10-28 CN claimed
EP-1333025-A1 CYANOPYRROLIDINE DERIVATIVES TAISHO PHARMACEUTICAL CO., LTD (JP) 2003-08-06 EP claimed
WO-2003040107-A1 IMIDAZOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND USE THEREOF FOR TREATMENT OF OBESITY BAYER PHARMACEUTICALS CORPORATION (US) 2003-05-15 WO claimed
EP-0874846-B1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 2003-04-02 EP claimed
CN-1066147-C Purine derivatives and process for preparing same 诺瓦提斯公司 2001-05-23 CN claimed
CN-1202896-A Purine derivatives and processes for their preparation 诺瓦提斯公司 1998-12-23 CN claimed
EP-0874846-A1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION Novartis AG (CH) 1998-11-04 EP claimed
WO-1997016452-A1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1997-05-09 WO claimed
CN-1028993-C Nucleic acid derivatives NIPPON KAYAKN K K (JP) 1995-06-21 CN claimed
US-5362915-A Inhibitors of enzymes/hydrolases; antiallergens, antiinflammatory agents SMITHKLINE BEECHAM PHARMA GMBH (DE) 1994-11-08 US claimed
CN-1059524-A New nucleic acid derivative NIPPON KAYAKN KABUSHIK KAISHA (JP) 1992-03-18 CN claimed